P-395 Updated Results from DREAMM-3, a Phase 3 Study of Belantamab Mafodotin (belamaf) Versus Pomalidomide Plus Dexamethasone in Patients (pts) with Relapsed/Refractory Multiple Myeloma (RRMM)
Clinical Lymphoma Myeloma and Leukemia（2024）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined